Literature DB >> 4039114

High-dose cisplatin therapy for cancer of the ovary: neurotoxicity.

C M Bagley, R H Rudolph, S E Rivkin, J L Yon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4039114     DOI： 10.7326/0003-4819-102-5-719

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  5 in total

1.  Treatment of non-small-cell lung cancer with vinblastine and very high-dose cisplatin. A Southwest Oncology Group study.

Authors:  S M Grunberg; J J Crowley; R B Livingston; F M Muggia; J S MacDonald; S K Williamson; R L Stephens
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

2.  Very high-dose cisplatin-induced ototoxicity: a preliminary report on early and long-term effects.

Authors:  C F Pollera; P Marolla; M Nardi; F Ameglio; L Cozzo; F Bevere
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

Review 3.  Evolution of high-dose cisplatin.

Authors:  W M Holleran; M W DeGregorio
Journal:  Invest New Drugs       Date:  1988-06       Impact factor: 3.850

4.  Efficacy and safety of high-dose cisplatin and cyclophosphamide with glutathione protection in the treatment of bulky advanced epithelial ovarian cancer.

Authors:  F Di Re; S Bohm; S Oriana; G B Spatti; F Zunino
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 5.  Cisplatin overdose: toxicities and management.

Authors:  Roger Y Tsang; Turki Al-Fayea; Heather-Jane Au
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.